Benzinga | Mar 23, 2021 04:02PM EDT

Bionano Genomics Q4 Sales $4.00M Beat $3.50M Estimate

Bionano Genomics (NASDAQ:BNGO) reported quarterly sales of $4.00 million which beat the analyst consensus estimate of $3.50 million by 14.29 percent. This is a 43.42 percent increase over sales of $2.79 million the same period last year.